TWITTER – DIGNITANA

Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen https://news.cision.com/dignitana-ab/r/innovative-treatment-for-hair-loss-from-chemotherapy-to-be-presented-at-stora-aktiedagen,c3672209

Dignitana AB Appoints Nomination Committee https://news.cision.com/dignitana-ab/r/dignitana-ab-appoints-nomination-committee,c3669495

Dignitana AB Publishes Q3 2022 Interim Report https://news.cision.com/dignitana-ab/r/dignitana-ab-publishes-q3-2022-interim-report,c3668490

Dignitana hires Johan Johansson to Head Operations, Research and Development https://news.cision.com/dignitana-ab/r/dignitana-hires-johan-johansson-to-head-operations--research-and-development,c3667855

Dignitana offentliggör riktad nyemission om cirka 25 miljoner SEK https://news.cision.com/se/dignitana-ab/r/dignitana-offentliggor-riktad-nyemission-om-cirka-25-miljoner-sek,c3650780

Load More

FACEBOOK – DIGNICAP

This message is only visible to admins.
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Error: Invalid OAuth access token. Type: OAuthException

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

HEADQUARTERS
Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy